Clinical Trial Update: A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing two new anxiolytic drug candidates in adults with social anxiety disorder, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Experimental drug 1
• Experimental drug 2

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 1 | Status: COMPLETED